Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: an effective but still broken option

Transl Lung Cancer Res. 2019 Dec;8(Suppl 4):S378-S382. doi: 10.21037/tlcr.2019.04.15.

Authors

Biagio Ricciuti¹, Giuseppe Lamberti², Fausto Roila¹, Giulio Metro¹

Affiliations

¹ Medical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy.
² Department of Experimental, Diagnostic and Specialty Medicine, Policlinico di Sant'Orsola University Hospital, Bologna, Italy.

No abstract available

Publication types

Editorial
Comment